METASTASES TO CENTRAL NERVOUS SYSTEM side effect
What is METASTASES TO CENTRAL NERVOUS SYSTEM ?Drugs associated with METASTASES TO CENTRAL NERVOUS SYSTEM
ARANESP ARIMIDEX AVASTIN BEVACIZUMAB CETUXIMAB CHAMPIX CHANTIX CYTARABINE DACARBAZINE ENBREL ETOPOSIDE FASLODEX GLIADEL HERCEPTIN HUMIRA INTRON KETOCONAZOLE LASIX LEUPLIN LEUPROLIDE MORPHINE NAVELBINE NEXAVAR PHENYTOIN PREMPRO PROCRIT PROPRANOLOL RABEPRAZOLE REBIF REMICADE REVLIMID SUNITINIB SUTENT TAMOXIFEN TARCEVA TEMODAL TEMODAR TEMOZOLOMIDE THALOMID TYKERB VAGIFEM VELCADE XELODA ZOMETA ZYPREXAMETASTASES TO CENTRAL NERVOUS SYSTEM : Cetuximab Side Effects Report #5646740-8
Health Professional from GERMANY reported CETUXIMAB problem on Feb 21, 2008. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, transient ischaemic attack, . CETUXIMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Cetuximab Side Effects Report #5682435-2
CETUXIMAB problem was reported by a Health Professional from GERMANY on Mar 19, 2008. Male patient, 75 years of age, weighting 167.6 lb, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, transient ischaemic attack, . CETUXIMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Rebif Side Effects Report #5683333-0
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 14, 2008. Female patient, 47 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, metastases to liver, metastatic malignant melanoma, . REBIF dosage: unknown. During the same period patient was treated with TYSABRI. Patient died on 02/20/2008.
METASTASES TO CENTRAL NERVOUS SYSTEM : Cetuximab Side Effects Report #5627480-8
CETUXIMAB problem was reported by a Health Professional from GERMANY on Feb 12, 2008. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . CETUXIMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, GEMCITABINE. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Avastin Side Effects Report #5587523-7
Consumer or non-health professional from UNITED STATES reported AVASTIN problem on Jan 03, 2008. Male patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . AVASTIN dosage: unknown. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Arimidex Side Effects Report #5588276-9
ARIMIDEX problem was reported by a Consumer or non-health professional from BRAZIL on Jan 10, 2008. Female patient, 51 years of age, was diagnosed with breast cancer and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, metastases to lung, multi-organ failure, . ARIMIDEX dosage: unknown. Patient was hospitalized. Patient died on 12/30/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Vagifem Side Effects Report #5589369-2
Physician from FRANCE reported VAGIFEM problem on Jan 08, 2008. Female patient, weighting 196.2 lb, was diagnosed with atrophic vulvovaginitis, depression, venous stasis, arrhythmia and was treated with VAGIFEM. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . VAGIFEM dosage: unknown. During the same period patient was treated with EFFEXOR, DELURSAN, PREVISCAN, KERLONE. Patient died on 12/30/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Herceptin Side Effects Report #5596187-8
HERCEPTIN problem was reported by a Consumer or non-health professional from ITALY on Jan 15, 2008. Female patient, 36 years of age, was diagnosed with breast cancer, breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . HERCEPTIN dosage: 4 MG/KG, UNK. During the same period patient was treated with PACLITAXEL. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Herceptin Side Effects Report #5548434-6
Consumer or non-health professional from UNITED STATES reported HERCEPTIN problem on Dec 10, 2007. Female patient, 64 years of age, was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . HERCEPTIN dosage: unknown. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Tarceva Side Effects Report #5573942-1
TARCEVA problem was reported by a Health Professional from UNITED STATES on Dec 05, 2007. Female patient, 54 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, metastasis, . TARCEVA dosage: (150 MG), ORAL. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Herceptin Side Effects Report #5484207-0
Consumer or non-health professional from UNITED STATES reported HERCEPTIN problem on Oct 02, 2007. Female patient, 64 years of age, was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . HERCEPTIN dosage: unknown. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Herceptin Side Effects Report #5501232-1
HERCEPTIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 18, 2007. Female patient was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . HERCEPTIN dosage: unknown. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Ketoconazole Side Effects Report #5444471-0
Physician from GERMANY reported KETOCONAZOLE problem on Sept 03, 2007. Female patient, 68 years of age, was diagnosed with blood cortisol increased and was treated with KETOCONAZOLE. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, off label use, . KETOCONAZOLE dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sunitinib Side Effects Report #5423522-3
SUNITINIB problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Female patient, 67 years of age, weighting 145.0 lb, was diagnosed with malignant melanoma, metastases to central nervous system and was treated with SUNITINIB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, status epilepticus, . SUNITINIB dosage: 37.5MG DAILY PO. During the same period patient was treated with RADIATION, DECADRON, OXYCODONE. Patient was hospitalized. Patient died on 06/29/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sutent Side Effects Report #5389527-6
Physician from PERU reported SUTENT problem on July 05, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, shock, . SUTENT dosage: unknown. Patient was hospitalized. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Bevacizumab Side Effects Report #5392592-3
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on July 11, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, radiation pneumonitis, . BEVACIZUMAB dosage: 15 MG/KG, SINGLE. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sutent Side Effects Report #5399524-2
Physician from PERU reported SUTENT problem on July 17, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, shock, . SUTENT dosage: unknown. Patient was hospitalized. Patient died on 05/01/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sutent Side Effects Report #5389527-6
SUTENT problem was reported by a Physician from PERU on July 05, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, shock, . SUTENT dosage: unknown. Patient was hospitalized. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Bevacizumab Side Effects Report #5392592-3
Physician from UNITED STATES reported BEVACIZUMAB problem on July 11, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, radiation pneumonitis, . BEVACIZUMAB dosage: 15 MG/KG, SINGLE. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sutent Side Effects Report #5399524-2
SUTENT problem was reported by a Physician from PERU on July 17, 2007. Male patient was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, shock, . SUTENT dosage: unknown. Patient was hospitalized. Patient died on 05/01/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Nexavar Side Effects Report #5655328-4
Consumer or non-health professional from UNITED STATES reported NEXAVAR problem on Feb 26, 2008. Female patient, 72 years of age, was diagnosed with renal cell carcinoma and was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, metastases to central nervous system, metastases to liver, metastases to lung, metastasis, thrombosis, . NEXAVAR dosage: TOTAL DAILY DOSE: 400 MG UNIT DOSE: 200 MG. During the same period patient was treated with DIGITEK, SOTALOL, NEXIUM, ARICEPT, ALLEGRA, WARFARIN. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Revlimid Side Effects Report #5679894-8
REVLIMID problem was reported by a Health Professional from GERMANY on Mar 17, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: lung neoplasm, metastases to central nervous system, . REVLIMID dosage: 25 MG, ORAL. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Humira Side Effects Report #5622429-6
Consumer or non-health professional from GERMANY reported HUMIRA problem on Jan 30, 2008. Female patient, 54 years of age, was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: inflammatory carcinoma of breast stage iv, metastases to central nervous system, metastases to liver, . HUMIRA dosage: unknown. During the same period patient was treated with INFLIXIMAB, ETANERCEPT, METHOTREXATE. Patient was hospitalized. Patient died on 05/15/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Chantix Side Effects Report #5635157-8
CHANTIX problem was reported by a Physician from IRELAND on Feb 11, 2008. Male patient was treated with CHANTIX. After drug was administered, patient experienced the following problems/side effects: headache, metastases to central nervous system, pneumonia, . CHANTIX dosage: unknown. Patient was hospitalized. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Morphine Side Effects Report #5637477-X
Consumer or non-health professional from reported MORPHINE problem on Feb 21, 2008. Female patient was diagnosed with procedural pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased, metastases to central nervous system, . MORPHINE dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Remicade Side Effects Report #5595395-X
REMICADE problem was reported by a Health Professional from PORTUGAL on Jan 10, 2008. Female patient, 41 years of age, was diagnosed with ankylosing spondylitis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: metastases to bone, metastases to central nervous system, metastases to liver, metastases to lung, metastasis, salivary gland cancer, . REMICADE dosage: unknown. Patient died on 08/09/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Revlimid Side Effects Report #5506970-2
Physician from UNITED STATES reported REVLIMID problem on Oct 24, 2007. Female patient, 63 years of age, was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to central nervous system, metastasis, multiple myeloma, . REVLIMID dosage: 25 MG, QD, ORAL. During the same period patient was treated with DEXAMETHASONE, VICODIN. Patient died on 09/09/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Tarceva Side Effects Report #5512594-3
TARCEVA problem was reported by a Physician from NETHERLANDS on Oct 22, 2007. Female patient, 73 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to central nervous system, skin ulcer, . TARCEVA dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Thalomid Side Effects Report #5518882-9
Physician from UNITED STATES reported THALOMID problem on Nov 06, 2007. Female patient, 78 years of age, was diagnosed with lymphoma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, multiple myeloma, neuralgia, . THALOMID dosage: 100 MG, 1 IN 1 D, ORAL ; 200 MG, 1 IN 1 D, ORAL ; ORAL. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Lasix Side Effects Report #5519269-5
LASIX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Female patient was diagnosed with lung cancer metastatic and was treated with LASIX. After drug was administered, patient experienced the following problems/side effects: dehydration, metastases to central nervous system, paraesthesia, . LASIX dosage: unknown. During the same period patient was treated with THALOMID, TARCEVA, DECADRON, VITAMINS. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Temodar Side Effects Report #5521526-3
Health Professional from UNITED STATES reported TEMODAR problem on Nov 16, 2007. Female patient, 65 years of age, weighting 141.0 lb, was diagnosed with malignant melanoma and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to central nervous system, metastases to lung, metastatic malignant melanoma, pneumonia staphylococcal, . TEMODAR dosage: 170MG PO DAILY. During the same period patient was treated with SUTENT. Patient was hospitalized. Patient died on 08/12/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Intron Side Effects Report #5526282-0
INTRON A problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2007. Male patient, weighting 205.5 lb, was treated with INTRON A. After drug was administered, patient experienced the following problems/side effects: depressed level of consciousness, metastases to central nervous system, . INTRON A dosage: 2684.5 MILLION IU. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Procrit Side Effects Report #5529454-4
Physician from UNITED STATES reported PROCRIT problem on Nov 19, 2007. Female patient, 52 years of age, was diagnosed with anaemia of malignant disease and was treated with PROCRIT. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, . PROCRIT dosage: unknown. During the same period patient was treated with DEXAMETHASONE. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Champix Side Effects Report #5480022-2
CHAMPIX problem was reported by a Physician from IRELAND on Aug 01, 2007. Male patient was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: headache, metastases to central nervous system, . CHAMPIX dosage: unknown. Patient was hospitalized. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Gliadel Side Effects Report #5484879-0
Physician from SPAIN reported GLIADEL problem on Dec 05, 2006. Male patient, 63 years of age, was diagnosed with glioblastoma multiforme and was treated with GLIADEL. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased, metastases to central nervous system, pneumocephalus, . GLIADEL dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Leuplin Side Effects Report #5491362-5
LEUPLIN problem was reported by a Physician from JAPAN on Oct 11, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPLIN. After drug was administered, patient experienced the following problems/side effects: condition aggravated, metastases to central nervous system, metastases to lung, prostate cancer stage iv, . LEUPLIN dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Zyprexa Side Effects Report #5447237-0
Physician from JAPAN reported ZYPREXA problem on Aug 29, 2007. Female patient, 62 years of age, was diagnosed with major depression and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: malaise, metastases to central nervous system, somnolence, . ZYPREXA dosage: 5 MG, DAILY (1/D). During the same period patient was treated with MILNACIPRAN, MAPROTILINE, AMITRIPTYLINE, ETIZOLAM. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Propranolol Side Effects Report #5447360-0
PROPRANOLOL problem was reported by a Physician from INDIA on Sept 05, 2007. Male patient, 58 years of age, was diagnosed with cachexia and was treated with PROPRANOLOL. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm progression, metastases to central nervous system, non-small cell lung cancer, . PROPRANOLOL dosage: 40MG 20MG BREAKFAST 10MG LUNCH 10MG EVENING ORAL. During the same period patient was treated with ETODOLAC, FAMOTIDINE, NEUROBION. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Thalomid Side Effects Report #5453511-4
Physician from UNITED STATES reported THALOMID problem on Sept 06, 2007. Female patient, 78 years of age, was diagnosed with lymphoma and was treated with THALOMID. After drug was administered, patient experienced the following problems/side effects: metastases to central nervous system, multiple myeloma, neuralgia, . THALOMID dosage: 100 MG, 1 IN 1 D, ORAL; 200 MG, 1 IN 1 D, ORAL; ORAL. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Sutent Side Effects Report #5454336-6
SUTENT problem was reported by a Physician from AUSTRALIA on Sept 05, 2007. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: disease progression, metastases to central nervous system, metastatic renal cell carcinoma, . SUTENT dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Avastin Side Effects Report #5456619-2
Consumer or non-health professional from UNITED KINGDOM reported AVASTIN problem on Sept 04, 2007. Female patient, weighting 172.6 lb, was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, metastases to central nervous system, . AVASTIN dosage: 780 MG, QD. During the same period patient was treated with PACLITAXEL. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Remicade Side Effects Report #5413475-6
REMICADE problem was reported by a Health Professional from UNITED KINGDOM on Aug 03, 2007. Male patient, 60 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: malignant neoplasm of thorax, metastases to central nervous system, . REMICADE dosage: unknown. During the same period patient was treated with ETANERCEPT, PREDNISOLONE, CALCICHEW, METHOTREXATE, FOLIC ACID, VENTOLIN, BECOTIDE. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Enbrel Side Effects Report #5420825-3
Physician from UNITED KINGDOM reported ENBREL problem on Aug 14, 2007. Male patient, weighting 144.0 lb, was diagnosed with rheumatoid arthritis, emphysema, asthma and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: lung cancer metastatic, metastases to central nervous system, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, VENTOLIN, BECOTIDE, ASCORBIC ACID, FOLIC ACID, PREDNISOLONE. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Rabeprazole Side Effects Report #5422316-2
RABEPRAZOLE problem was reported by a Physician from JAPAN on Aug 06, 2007. Male patient, 64 years of age, was diagnosed with reflux oesophagitis and was treated with RABEPRAZOLE. After drug was administered, patient experienced the following problems/side effects: memory impairment, metastases to central nervous system, neoplasm malignant, . RABEPRAZOLE dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Remicade Side Effects Report #5425910-8
Health Professional from UNITED KINGDOM reported REMICADE problem on Aug 16, 2007. Male patient, weighting 154.3 lb, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: lung neoplasm malignant, metastases to central nervous system, . REMICADE dosage: unknown. During the same period patient was treated with ASCORBIC ACID, TRAMADOL, METHOTREXATE, PREDNISOLONE, BECOTIDE, CALCICHEW, CODYDRAMOL, FOLIC ACID. Patient recovered.
METASTASES TO CENTRAL NERVOUS SYSTEM : Etoposide Side Effects Report #5444318-2
ETOPOSIDE problem was reported by a Physician from ISRAEL on Aug 23, 2007. Male patient, 20 years of age, was diagnosed with neoplasm malignant, ovarian cancer and was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: glioblastoma multiforme, metastases to central nervous system, . ETOPOSIDE dosage: 75 MG/M2, DAILY X 3 COURSES. During the same period patient was treated with CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient died on 08/01/2005.
METASTASES TO CENTRAL NERVOUS SYSTEM : Morphine Side Effects Report #5379239-7
Consumer or non-health professional from reported MORPHINE problem on July 03, 2007. Female patient was diagnosed with procedural pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased, metastases to central nervous system, . MORPHINE dosage: unknown. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Faslodex Side Effects Report #5382503-9
FASLODEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2007. Female patient, 51 years of age, was diagnosed with breast cancer and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome, metastases to central nervous system, . FASLODEX dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, LORTAB, NADOLOL, ZOFRAN, VITAMIN B6. Patient died on 04/02/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Leuprolide Side Effects Report #5390842-0
Physician from JAPAN reported LEUPROLIDE ACETATE problem on July 10, 2007. Male patient, 74 years of age, was diagnosed with prostate cancer stage iv and was treated with LEUPROLIDE ACETATE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, metastases to central nervous system, metastases to lung, prostate cancer, . LEUPROLIDE ACETATE dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with CASODEX. Patient died.
METASTASES TO CENTRAL NERVOUS SYSTEM : Faslodex Side Effects Report #5401138-2
FASLODEX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2007. Female patient, 51 years of age, was diagnosed with breast cancer and was treated with FASLODEX. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome, metastases to central nervous system, . FASLODEX dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, LORTAB, NADOLOL, ZOFRAN, VITAMIN B6. Patient died on 04/02/2007.
METASTASES TO CENTRAL NERVOUS SYSTEM : Morphine Side Effects Report #5379239-7
Consumer or non-health professional from reported MORPHINE problem on July 03, 2007. Female patient was diagnosed with procedural pain and was treated with MORPHINE. After drug was administered, patient experienced the following problems/side effects: intracranial pressure increased, metastases to central nervous system, . MORPHINE dosage: unknown. Patient died.